SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM AT PENN

摘要 我们提出了一个新的培训计划，在癌症研究的外科住院医生追求的职业生涯， 学术外科肿瘤学理由是全国范围内缺乏外科医生科学家。一 T32计划将使我们能够培养高素质的外科实习生，使他们能够为新的 癌症治疗和发现，改善癌症患者的护理，并指导未来的学员。T32 学员须已完成三年的外科临床研究生课程。2年T32 培训计划将提供深入的研究经验，假设制定，实验 设计，研究技术，数据分析，口头和书面陈述。完成T32后 计划，学员返回诊所的最后2个临床年的住院医师。大多数人追求 在完成住院医师培训后，再获得2年的研究金专业化。的最终目标 该计划旨在培训外科医生科学家在完成手术后进行肿瘤学研究 培训并成为学术外科肿瘤学的领导者。我们建议在第一阶段共招收2名学员 第二年有5名学员，第3-5年每年有6名学员。该计划将有一个 基本/翻译轨道和临床轨道，这反映了我们的教师和 我们居民的利益。该计划将利用巨大的研究机会和基础设施， 佩雷尔曼医学院和宾夕法尼亚大学，包括艾布拉姆森癌症研究所， 中心该计划是外科部门的一个主要优先事项，该部门有着悠久的历史， 培训外科医生科学家和学术领导人。T32计划将由该计划管理 主任、2名副项目主任和一个指导委员会，由经验丰富的专家提供意见 顾问（3名内部顾问和2名外部顾问）。16名导师分别来自外科和其他8个部门。的 导师有积极的资金，辅导的跟踪记录，以及各种学科的专业知识， 包括肿瘤免疫学、癌细胞生物学、癌症成像和临床癌症研究。的 拟议的课程是健全的，将根据每个受训人员的具体需要量身定制。会有 指导研究的负责任行为，资助写作研讨会，口头陈述技巧 会议和期刊俱乐部。T32学员还将有机会获得高级学位， 比如转化医学或临床流行病学硕士，甚至是博士。我们部门 通过招聘妇女和任职人数不足的妇女， 少数群体

ABSTRACT We propose a new program of training in cancer research for surgery residents pursuing a career in academic Surgical Oncology. The rationale is that there is a nationwide shortage of surgeon-scientists. A T32 program would enable us to train high caliber surgical trainees so that they can contribute to new cancer therapies and discoveries, improve the care of cancer patients, and mentor future trainees. T32 trainees will have already completed 3 years of postgraduate clinical training in surgery. The 2-year T32 training program will provide an intensive research experience in hypothesis formulation, experimental design, research techniques, data analysis, and oral and written presentation. After completing the T32 program, the trainees return to the clinic for the 2 final clinical years of residency. Most pursue an additional 2 years of fellowship specialization after finishing residency training. The ultimate objective of the program is to train surgeon-scientists to perform oncologic research upon completion of their surgical training and become leaders in academic surgical oncology. We propose a total of 2 mentees in the first year, 5 mentees in the second year, and six mentees per year in years 3-5. The program will have a Basic/Translational Track and a Clinical Track, which reflects the strengths of our faculty and the interests of our residents. The program will leverage the vast research opportunities and infrastructure of the Perelman School of Medicine and the University of Pennsylvania, including the Abramson Cancer Center. The program is a major priority of the Department of Surgery, which has a longstanding history of training surgeon-scientists and academic leaders. The T32 Program will be managed by the Program Director, 2 Associate Program Directors, and a Steering Committee, with input from highly experienced advisors (3 internal and 2 external). The 16 mentors are based in Surgery and 8 other departments. The mentors have active funding, a track record of mentoring, and expertise in a wide variety of disciplines, including tumor immunology, cancer cell biology, cancer imaging, and clinical cancer research. The proposed curriculum is robust and will be tailored to the specific needs of each trainee. There will be instruction in the Responsible Conduct of Research, grant writing workshops, oral presentation skill sessions, and journal clubs. T32 trainees will also have the opportunity to obtain an advanced degree, such as a Masters in Translational Medicine or Clinical Epidemiology, and even a PhD. Our department has several initiatives to promote diversity through the recruitment of women and underrepresented minorities.